Quantification of three antineoplastic agents in urine using the UniSpray ionisation source

Eline Verscheure1, Matteo Creta2, Dorian Vanneste1

  • 1Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Abstract

Insights

A new UPLC-MS/MS method accurately quantifies occupational exposure to cyclophosphamide, ifosfamide, and paclitaxel in healthcare workers. This sensitive technique helps monitor antineoplastic agent exposure in the workplace.

Area of Science:

  • Analytical Chemistry
  • Occupational Health

Background:

  • Decreased antineoplastic agent exposure due to safety measures.
  • Need for sensitive methods to quantify low-level occupational exposure in healthcare workers.

Purpose of the Study:

  • Develop and validate a sensitive UPLC-MS/MS method for simultaneous detection of cyclophosphamide, ifosfamide, and paclitaxel.
  • Assess occupational exposure to these antineoplastic agents in healthcare workers.

Main Methods:

  • Urine sample extraction using Novum cartridges.
  • Separation on a C18 column.
  • Ionization via UniSpray and detection with MS/MS.

Main Results:

  • Quantifiable concentrations of at least one antineoplastic agent found in 17 out of 83 healthcare worker samples.
  • Validated method with low limit of quantification (LLOQ) for cyclophosphamide (0.05 ng/mL), ifosfamide (0.3 ng/mL), and paclitaxel (0.7 ng/mL).

Conclusions:

  • A sensitive and validated UPLC-MS/MS method for simultaneous quantification of key antineoplastic agents in urine was successfully developed.
  • The method is suitable for assessing occupational exposure in healthcare settings.

Related Concept Videos